ProRx LLC — Federal Records

fda 14 records

FDA Drug Recall: Semaglutide Injection, 10 mg/4 mL (2.5 mg/mL), 4mL Multidose Vial, For Subcutane 2025-11-05

Class II — Lack of Assurance of Sterility

View Source

FDA Drug Recall: Semaglutide Injection, 6mg/2.4mL (2.5 mg/mL), 2.4mL Multidose Vial, For Subcutan 2025-11-05

Class II — Lack of Assurance of Sterility

View Source

FDA Drug Recall: Semaglutide Injection, 2.5mg/1mL (2.5 mg/mL), 1mL Multidose Vial, For Subcutaneo 2025-11-05

Class II — Lack of Assurance of Sterility

View Source

FDA Drug Recall: Semaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutan 2025-11-05

Class II — Lack of Assurance of Sterility

View Source

FDA Drug Recall: Tirzepatide Injection, 27 mg/3 mL (9 mg/mL), 3mL Multidose Vial, For Subcutaneou 2025-11-05

Class II — Lack of Assurance of Sterility

View Source

FDA Drug Recall: Semaglutide Injection, 12.5/5mL (2.5 mg/mL), 5mL Multidose Vial, For Subcutaneou 2025-11-05

Class II — Lack of Assurance of Sterility

View Source

FDA Drug Recall: Semaglutide Injection, 5 mg/2 mL (2.5 mg/mL), 2mL Multidose Vial, For Subcutaneo 2025-11-05

Class II — Lack of Assurance of Sterility

View Source

FDA Drug Recall: Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Comp 2024-09-11

Class II — Lack of Assurance of Sterility

View Source

FDA Drug Recall: Semaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass via 2024-09-11

Class II — Lack of Assurance of Sterility

View Source

FDA Drug Recall: Semaglutide / Cyanocobalamin Injection: 2.5/0.5 mg/mL, 2 mL Multiple Dose Vial, 2024-09-11

Class II — Lack of Assurance of Sterility

View Source

FDA Drug Recall: SEMAGLUTIDE 5mg/2mL (2.5mg/mL), Rx Only 2 mL Multiple Dose Vial, Rx Only, Compou 2024-09-11

Class II — Lack of Assurance of Sterility

View Source

FDA Drug Recall: TIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProR 2024-09-11

Class II — Lack of Assurance of Sterility

View Source

FDA Drug Recall: TIRZEPATIDE 20 mg/2mL (10/mg/mL), Rx Only, 2mL Multiple Dose Vial, Mfd by: ProR 2024-09-11

Class II — Lack of Assurance of Sterility

View Source

FDA Drug Recall: SEMAGLUTIDE 10mg/4mL (2.5mg/mL), 4 mL Multiple Dose Vial, Rx Only, Compounded Dr 2024-09-11

Class II — Lack of Assurance of Sterility

View Source

nppes 1 records

NPI Provider: PRORX, INC.

NPI: 1285203406 | CA

View Source

Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts

No spam. Only major updates. Unsubscribe anytime.